Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This study suggests that elevated aldosterone may contribute to androgenic alopecia development and its association with higher hypertension prevalence, emphasizing the importance of blood pressure screening in affected patients.

This review discusses the potential of drug therapies like finasteride for treating androgenetic alopecia, highlighting its ability to prevent hair loss and promote regrowth in clinical trials with men.

This study found a significant relationship between the severity of androgenetic alopecia in men and a negative impact on their quality of life.

Early hair loss may indicate risk of insulin resistance.

This review discusses the development of an algorithmic guideline for treating androgenetic alopecia in Asian patients, using the BASP classification to address limitations of previous guidelines, and reports no clinical results.

This study observed that white dots, focal atrichia, and honeycomb pigmentation on the scalp were significantly associated with the severity of androgenetic alopecia in men under forty.

This study found that overexpression of the lncRNA AC010789.1 in hair follicle stem cells may suppress androgen alopecia progression by modulating several molecular pathways, suggesting a potential new treatment strategy.

ALDOA levels drop in hair cells during hair loss.

This article comments on previous studies linking severe androgenetic alopecia to increased vulnerability to COVID-19 and highlights ongoing research into antiandrogen therapies as potential treatments.

This review discusses recent research on the use of concentrated growth factor (CGF) for treating androgenetic alopecia, highlighting its potential to enhance hair regrowth and improve hair density but noting the need for high-quality clinical trials.